Bollard Group’s Bio-Techne TECH Stock Holding History

Bollard Group’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-15	Closed	-$1K	–	623
2023 Q2	$1K	Buy	+15	New	+$1.21K	﹤0.01%	641

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bollard Group's TECH Position: Q3 2023 in Review

Bollard Group sold out of Bio-Techne (TECH) in Q3 2023, closing a stake of 15 shares — an estimated $1K sold.

Bollard Group first reported a position in TECH in Q2 2023 and held it in 1 quarter. The position peaked at $1K in Q2 2023. 530 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

Bollard Group reported no remaining Bio-Techne position as of Q3 2023 after selling out during the quarter.
Bollard Group sold 15 Bio-Techne shares in Q3 2023, an estimated $1K.
Bollard Group first reported a position in Bio-Techne in Q2 2023 and held it in 1 quarter.
Bollard Group's Bio-Techne position peaked at $1K in Q2 2023.
530 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on Bollard Group's 13F filing for Q3 2023, filed 14 Nov 2023.